Press Releases
Videojet showcases four new products at Interpack 2017
Innovation is the focus in 2017, as Videojet showcases four brand new products from three technologies at Interpack designed to deliver maximum uptime, unprecedented reliability and attractive total cost of ownership figures. These four new systems...
Press Releases
Aldeyra Therapeutics Confirms FDA Orphan Drug Designation for ADX-102 in Sjogren-Larsson
Aldeyra Therapeutics, Inc. , a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous aldehydes. A naturally occurring class of pro-inflammatory and toxic molecules announced that the United States FDA has granted Aldeyra's...
Press Releases
Oramed Granted European Patent For Combination Oral Insulin And Glp-1 Analog Capsule
Oramed Pharmaceuticals Inc (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that the European Patent Office has granted the Company a patent titled, “Methods and Compositions for Treating Diabetes: ...
Press Releases
Food Processors Get a 360-Degree View of Line Performance with Mettler-Toledo’s ProdX 2.0
To supportglobal food manufacturers in meeting the documentation and active managerial control requirements of the Food Safety Modernisation Act (FSMA). When exporting their products to the US,Mettler-Toledo Product Inspection has launched the enhanced ProdX™ 2.0 data...
Press Releases
DiscoverX Partners with B’SYS GmbH to Expand SAFETYscan In Vitro Pharmacological Profiling Services
DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development announced their partnership with B’SYS GmbH to expand DiscoverX’s SAFETYscan in vitro pharmacological profiling services for ion channel assays. SAFETYscan services provide...
Press Releases
Eyevensys receives French regulatory approval to advance EyeCET platform
Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases. ...
Press Releases
Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study
Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers for mitochondrial dysfunction and synaptic loss. Imanova has been awarded an additional £1m of strategic funding from the MRC...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















